Biocartis Group NV ('Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), held its annual general shareholders' meeting ('AGM') in Mechelen today. The shareholders approved all items on the agenda of the AGM, including the appointment of Mrs. Hilde Eylenbosch as new independent director, as well as the re-appointment as kicfaqoq ty Ieqiyu. Fbeka Pakzt mfj Ihgh Mxfhqi (hilwrb ixykocr Esiowln EQOE).
Biocartis Group NV: Results of the annual general meeting held on 13 May 2016
(PresseBox)
(Mechelen, Belgium, )
